Literature DB >> 6111406

Serum-mediated inhibition of lymphocyte Fc gamma receptors in glomerulonephritis.

A Bakkaloglu, G P Sandilands, J D Briggs, J R Anderson.   

Abstract

Non-complement-fixing immune complexes were detected by EA rosette inhibition in the sera of 47% of patients with primary glomerulonephritis (GN) and 60% with GN associated with systemic disease. Fifteen patients with minimal-change nephrotic syndrome (MCNS) in relapse produced significantly greater inhibition than the sera from 11 who were in remission.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6111406      PMCID： PMC1537172     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  19 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  Serum beta-1C globulin in glomerulonephritis and systemic lupus erythematosus.

Authors:  S P Gotoff; E W Isaacs; R C Muehrcke; R D Smith
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

4.  Interaction between 'sensitized lymphocytes' and antigen in vitro. IV. Studies on the mechanism of release of skin reactive and macrophage migration-inhibitory factors.

Authors:  E Pick; J L Turk
Journal:  Immunology       Date:  1972-01       Impact factor: 7.397

5.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

6.  Cryoglobulins. III. Further studies on the nature, incidence, clinical, diagnostic, prognostic, and immunopathologic significance of cryoproteins in renal disease.

Authors:  R M McIntosh; W R Griswold; W B Chernack; G Williams; J Strauss; D B Kaufman; M N Koss; J R McIntosh; R Cohen; R Weil
Journal:  Q J Med       Date:  1975-04

7.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus sera.

Authors:  T Morito; K Tanimoto; Y Hashimoto; Y Horiuchi; T Juji
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

9.  Detection of circulating soluble immune complexes in patients with various renal diseases.

Authors:  W D Stühlinger; P J Verroust; L Morel-Maroger
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

10.  The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases.

Authors:  M D Smith; T M Barratt; A R Hayward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.